The front line of cancer warfare: CAR-T vs. CAR-macrophage therapies

In the exploration of cancer treatment modalities, an article published in Biomolecules and Biomedicine titled “CAR-macrophage versus CAR-T for solid tumors: The race between a rising star and a superstar,” offers an examination of the evolving landscape in oncological therapeutics.

Leave A Comment

Your email address will not be published. Required fields are marked *